On 5 December 2024 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at The Carlton Hotel in Moscow. This year Lidings expertise is highly praised in 17 key practice areas.

Lidings’ Intellectual Property practice team succeeded in obtaining cancellation of registration of a drug in a dispute against the holder of the marketing authorisation (MA) due to the fact that during the process of registration of a generic drug product the Ministry of Health of Russia received false information from the holder of the MA.

Lidings has signed a cooperation agreement with Leadvisor Global, an international network of consultants. The firm has become the first national legal counsel to represent Russia.

We are delighted to announce that Lidings has updated The Pharma Legal Handbook: Russia - practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia.

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2024 the firm is ranked among the TOP leading legal advisors in Russia. 

In March 2024 Lidings partner Stepan Guzey visited the UAE (Dubai), Oman (Muscat), the Kingdom of Saudi Arabia (Riyadh) and Bahrain (Manama) during his regular business trip to the Middle East.

During the two-week visit Stepan held more than 25 business meetings with representatives of leading local law firms and government agencies to establish and strengthen partnerships, as well as discussed current and future projects with clients to whom Lidings provides comprehensive legal support for both outward and inward investment projects in the Middle East region.

On 7 December 2023 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at The Carlton Hotel in Moscow. This year Lidings expertise is highly praised in 15 key practice areas.

Lidings’ IP team has successfully secured recognition of the Doppelherz brand as a well-known trademark specifically for dietary supplements, setting a valuable precedent. The interests of the client, the German pharmaceutical company Queisser Pharma, which owns the brand, were represented by Boris Malakhov, Partner, and Vladislav Ryabov, Senior Associate.

Lidings Intellectual Property team has helped a major Russian manufacturer of pharmaceuticals, Pharmnovations, to achieve the annulment of the marketing authorization for a generic drug of a competitor company.

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2023 the firm is ranked among the TOP leading legal advisors in Russia.